Literature DB >> 23629678

Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.

Ezequiel Bellorin-Font1, Pablo Ambrosoni, Raúl G Carlini, Aluizio B Carvalho, Ricardo Correa-Rotter, Alfonso Cueto-Manzano, Aquiles Jara, Vanda Jorgetti, Armando L Negri, Armando Negri, Inés Olaizola, Isidro Salusky, Eduardo Slatopolsky, José R Weisinger.   

Abstract

The clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of chronic kidney disease mineral and bone disorders (CKD-BMD) in adults, of the Latin American Society of Nephrology and Hypertension (SLANH) comprise a set of recommendations developed to support the doctor in the management of these abnormalities in adult patients with stages 3-5 kidney disease. This excludes changes associated with renal transplantation. The topics covered in the guidelines are divided into four chapters: 1) Evaluation of biochemical changes, 2) Evaluation of bone changes, 3) Evaluation of vascular calcifications, and 4) Treatment of CKD-MBD. The guidelines are based on the recommendations proposed and published by the Kidney Disease: Improving Global Outcomes (KDIGO) for the prevention, diagnosis, evaluation and treatment of CKD-MBD (KDIGO Clinical practice guidelines for the diagnosis, evaluation, prevention and treatment of Chronic Kidney Disease Mineral and Bone Disorder [CKD-MBD]), adapted to the conditions of patients, institutions and resources available in Latin America, with the support of KDIGO. In some cases, the guidelines correspond to management recommendations directly defined by the working group for their implementation in our region, based on the evidence available in the literature. Each chapter contains guidelines and their rationale, supported by numerous updated references. Unfortunately, there are few controlled studies with statistically sufficient weight in Latin America to support specific recommendations for the region, and as such, most of the references used correspond to studies carried out in other regions. This highlights the need to plan research studies designed to establish the current status of mineral and bone metabolism disorders in Latin America as well as defining the best treatment options for our population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23629678     DOI: 10.3265/Nefrologia.pre2013.Feb.11945

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  9 in total

1.  Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.

Authors:  Rosilene M Elias; Rosa M A Moysés
Journal:  Int Urol Nephrol       Date:  2017-07-10       Impact factor: 2.370

Review 2.  Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD.

Authors:  Berthold Hocher; Andreas Pasch
Journal:  Kidney Dis (Basel)       Date:  2017-06-16

Review 3.  Dietary interventions for mineral and bone disorder in people with chronic kidney disease.

Authors:  Zhuangzhu Liu; Guobin Su; Xinfeng Guo; Yifan Wu; Xusheng Liu; Chuan Zou; Lei Zhang; Qianchun Yang; Yuan Xu; Weizhong Ma
Journal:  Cochrane Database Syst Rev       Date:  2015-09-16

4.  Vitamin D & its analogues in type 2 diabetic nephropathy: a systematic review.

Authors:  Mrunalini K Chokhandre; Mahmoud I Mahmoud; Tahir Hakami; Mohammed Jafer; Aadil S Inamdar
Journal:  J Diabetes Metab Disord       Date:  2015-07-15

5.  Optimizing Protein Intake and Nitrogen Balance (OPINiB) in Adult Critically Ill Patients: A Study Protocol for a Randomized Controlled Trial.

Authors:  Matteo Danielis; Giulia Lorenzoni; Laura Cavaliere; Mariangela Ruffolo; Luca Peressoni; Amato De Monte; Rodolfo Muzzi; Fabio Beltrame; Dario Gregori
Journal:  JMIR Res Protoc       Date:  2017-05-09

6.  Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease: A prospective pilot study.

Authors:  Chunhua Zhang; Shixiang Wang; Sumei Zhao; Xiaodong Zhang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

7.  Surgical Outcomes of Subtotal Parathyroidectomy for Renal Hyperparathyroidism.

Authors:  Min Song Kim; Gheun-Ho Kim; Chang Hwa Lee; Joon-Sung Park; Ji Young Lee; Kyung Tae
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-02-21       Impact factor: 3.372

8.  Adherence to multidisciplinary care in a prospective chronic kidney disease cohort is associated with better outcomes.

Authors:  Pablo Rios; Laura Sola; Alejandro Ferreiro; Ricardo Silvariño; Verónica Lamadrid; Laura Ceretta; Liliana Gadola
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

9.  Long-term therapeutic outcomes of papillary thyroid carcinoma with concomitant hyperparathyroidism: A single center case-control study.

Authors:  Chih-Yiu Tsai; Szu-Tah Chen; Chuen Hsueh; Yann-Sheng Lin; Jen-Der Lin
Journal:  Biomed J       Date:  2020-02-27       Impact factor: 4.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.